BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 4, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 23, 2000
View Archived Issues
Mycophenolic acid reduces HIV viral replication
Read More
Fas gene highlighted in hepatitis research
Read More
Research reveals new gene target for osteoporosis treatment
Read More
Peruvian plants found to be active against tuberculosis
Read More
NIH licensing opportunity: radiation therapy optimization technology
Read More
Combination antiviral therapies offered for licensing by NIH
Read More
Diatide's radiodiagnostic receives positive opinion for E.U. approval
Read More
Newly issued patents cover related series of novel amides
Read More
British Biotech partners with De Novo for antibacterial drug discovery
Read More
Novel VLA-4 inhibitors reported by Elan and Wyeth-Ayerst
Read More
Kinase inhibitors demonstrate apoptotic activity in chronic lymphocytic leukemia
Read More
Protein levels indicate severity of prostate cancer tumors
Read More
Vivelle receives FDA approval for prevention of osteoporosis
Read More
Efficacy of endothelin receptor antagonists in chronic heart failure compared
Read More
Highly selective m4 muscarinic receptor antagonist described
Read More
In vivo results presented for PARP inhibitor GPI-6150
Read More
Abbott describes novel selective MMP-2/MMP-9 inhibitors
Read More
Analgesic agents under development at Meiji Seika
Read More
Kyorin receives patent for new series of AMPA antagonists
Read More
New VLA-4 inhibitors under development at Aventis
Read More
NIH awards Epimmune grant for HIV-1 vaccine development
Read More
Aronex's amended Atragen NDA accepted for FDA review
Read More
Chiron to acquire PathoGenesis; TOBI clears E.U. mutual recognition process
Read More
Seven key sessions and symposia from XXII ESC Congress available to Daily Essentials readers
Read More